OTC Monograph 'Disruption' Could Ride Along With PDUFA Reauthorization – CHPA Exec

Changing the monograph process is an area "where disruption can be positive," CEO Scott Melville says at CHPA conference. Best chance for monograph reform could be tying it to user fee reauthorization, but that could be a lengthy process.